The FDA has approved Neurocrine Bioscience’s Ingrezza, the first ever licensed treatment for tardive dyskinesia or TD. The condition is characterised by uncontrollable movement of the body or ...

AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa ...

Over the past few years, there has been notable advancement in the field of Quantified Gait Analysis (QGA), thanks to machine learning techniques. QGA and gait prediction are areas where Deep learning ...

This paper investigates the potential of detecting stroke gaits by Deep Neural Network (DNN) models based on data from different sensor systems. Stroke survivors usually experience partial disability ...